Clinical Pharmacokinetics of Anti-Parkinsonian Drugs
- 1 September 1987
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 13 (3) , 141-178
- https://doi.org/10.2165/00003088-198713030-00002
Abstract
Of the neurological disorders, none can claim a battery of therapeutic agents based upon as rational a pharmacology as can Parkinson’s disease. In this review, the clinical pharmacokinetics of the...Keywords
This publication has 99 references indexed in Scilit:
- Pharmacokinetics of Diphenhydramine and a Demethylated Metabolite Following Intravenous And Oral AdministrationThe Journal of Clinical Pharmacology, 1986
- Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor AgonistScience, 1979
- Experiences with L-deprenyl in ParkinsonismJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- L-deprenyl treatment of on-off phenomena in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Anticholinergic and membrane activities of amantadine in neuromuscular transmissionNature, 1976
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- 3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrierLife Sciences, 1975
- Pharmacokinetics of diphenhydramine in manJournal of Pharmacokinetics and Biopharmaceutics, 1975
- The role of the liver in the clearance ofl-dopa from plasmaJournal of Pharmacokinetics and Biopharmaceutics, 1975